You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Automated Manufacture of Damage Detecting, Self-Healing Composite Cryogenic Pressure Vessels

    SBC: AURORA FLIGHT SCIENCES CORPORATION            Topic: T1002

    During Phase I, Aurora Flight Sciences and the University of Massachusetts Lowell propose to demonstrate the feasibility of enhancing a commercially available out-of-autoclave (OOA) carbon prepreg material system (e.g. IM7/5320) via embedded structural health monitoring (SHM) and self-healing capabilities, which can be manufactured by an automated fiber placement (AFP) machine. This proposed "sma ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  2. Novel Metal Organic Framework Synthesis for Spacecraft Oxygen Capture

    SBC: BUSEK CO., INC.            Topic: T602

    Busek and University of Utah propose to develop novel metal organic framework (MOF) material to efficiently capture oxygen in spacecraft cabin environment. The proposed novel MOF is postulated to be capable of separating oxygen from ambient air with high efficiency, and at the same time, be stable to moisture and resistant to decomposition. In Phase I, our team shall synthesize the proposed MOF an ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  3. Heat Harvesting by Artificial Muscles

    SBC: LYNNTECH INC.            Topic: T301

    NASA emphasizes the need to implement energy harvesting in its future mission activities. By harvesting energy from the ambient surroundings, there is less dependence on a primary power supply (e.g., combustion engines, fuel cells, batteries, solar cells, etc.). Overall power consumption is thereby reduced, equipment weight goes down and logistical supply needs are simplified. Future NASA mission ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  4. In-Situ EBCs for High Performance Composite Propulsion Components

    SBC: PHYSICAL SCIENCES INC.            Topic: T1202

    Silicon Carbide based ceramic matrix composites (CMCs) offer the potential to fundamentally change the design and manufacture of aeronautical and space propulsion systems to significantly increase performance and fuel efficiency over current metal-based designs. Physical Sciences Inc. (PSI) and our team members at the University of California Santa Barbara (UCSB) will develop, design and fabricat ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  5. Low Cost Flexible Graphene-Based Digital Beam Forming Phased-Array Antennas

    SBC: OMEGA OPTICS, INC.            Topic: T501

    Communication technologies support all NASA space missions, among which autonomous communication technologies are extremely beneficial to future missions. Communication technologies will expand mankind's understanding of planet earth and the universe. As the needs to gather more data, even more advanced antenna technologies will be essential to deliver orders of magnitude more data. Low cost high ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  6. New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cyto

    SBC: Nirvana Sciences, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Polychromatic flow cytometry [FC] is one of the most powerful analytical techniques routinely used in immunology. Flow cytometry plays a critical role in several growing clinical applications: leukemia and lymphoma immunophenotyping for diagnosis and sub-categorization (now using 8-10 colors); in CD4/CD8 measurement in HIV-positive patients; and in HLA typing f ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Development of small near-infrared laser system capable of improving immune respo

    SBC: SEMINEX CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): The broad and long-term objective of this project is to amplify the effectiveness of vaccines without the use of chemical or biological adjuvants. We will address this objective by demonstrating the feasibility for small laser- based devices to enhance responses to intradermal vaccination. A number of investigators have shown that a promising new way to make va ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Ex vivo purging strategy for treatment of multiple myeloma

    SBC: DNATRIX INC            Topic: NCI

    DESCRIPTION (provided by applicant): The ultimate goal of this application is to develop a novel ex vivo purging method using myxoma virus (MYXV), a rabbit-specific poxvirus, to improve the clinical outcomes in treatment of multiple myeloma (MM). MM is aclonal plasma cell malignancy that has to date resisted essentially all therapeutic strategies. Currently, the standard of care for patients wit ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Therapeutic Utility of renalase and renalase peptides in cisplatin-mediated renal

    SBC: BESSOR PHARMA, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Cisplatin is a cornerstone therapy for a number of cancers including testicular, bladder, ovarian and lung. It is also used to treat cancers in children. In all cases there is a high incidence of acute kidney injury (AKI) that can also lead to later stage kidney damage. This risk limits its use. We have found in pilot studies that renalase, or peptide fragment ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government